Evaluation of a Community Pharmacist Managed Asthma Consultation Service
Launched by ZAHAVA ROSENBERG-YUNGER · May 9, 2016
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Provided written consent
- • Intending to refill all asthma-related prescriptions at the study pharmacy
- • Diagnosed with asthma by a physician or nurse practitioner
- • Taking inhaled corticosteroids for which the dose and/or medication has remained unchanged for at least 2 months
- • 18 years of age or older
- • Uncontrolled asthma (defined as in the past 4 weeks the patient has used their rescue medications 4 or more times in a given week and/or the patient has woken up in the night from their asthma in a given week).
- Exclusion Criteria:
- • Pregnant women
- • Unable or unwilling to return to the pharmacy for scheduled visits
- • Unable to speak English language well enough to communicate with the pharmacist and complete the questionnaires independently
- • Terminal illness or poor prognosis (life expectancy less than 3 years)
- • History of alcoholism or drug abuse
- * Comorbidities/health issues:
- • Chronic obstructive pulmonary disorder (emphysema; chronic bronchitis)
- • Acute respiratory infection
- • Pulmonary fibrosis
- • Cancer (in the past 5 years preceding enrolment)
- • Organ transplantation
- • Dementia, cognitive impairment or other psychiatric disorder (Cognitive Impairments such as those found under the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) common Axis I and Axis II disorders
- • Any other health issue that may hinder performance on pulmonary function test
- • Enrolled in an Employee Assistance Program for disease management within 6 months preceding the study enrolment date OR planning to enroll in the next 12 months
- • Enrolled in another asthma management/clinical study OR planning to enroll in a similar study in the next 12 months
- • Had a MedsCheck or MedsCheck Follow-Up done within the 3-month period preceding the anticipated date of the first study appointment
- • Patients who do not wish their physician to be notified of their participation
About Zahava Rosenberg Yunger
Zahava Rosenberg-Yunger is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative trial designs and rigorous methodologies. With a focus on ethical standards and patient safety, the organization collaborates with leading research institutions and healthcare professionals to facilitate the development of cutting-edge therapies across various therapeutic areas. Leveraging a wealth of expertise in clinical operations and regulatory compliance, Zahava Rosenberg-Yunger aims to streamline the clinical trial process, ensuring efficient and effective study execution while contributing valuable insights to the scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Zahava Rosenberg-Yunger, PhD
Principal Investigator
Ryerson University; Ontario Pharmacists Association
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials